Buscar en
Endocrinología y Nutrición
Toda la web
Inicio Endocrinología y Nutrición Actualización de pruebas funcionales en endocrinología
Journal Information
Vol. 50. Issue 6.
Pages 250-256 (June 2003)
Share
Share
Download PDF
More article options
Vol. 50. Issue 6.
Pages 250-256 (June 2003)
Full text access
Actualización de pruebas funcionales en endocrinología
Dynamic tests of endocrine function: an update
Visits
20982
R. Casamitjana
Corresponding author
rcasamit@clinic.ub.es

Correspondencia: Dra. R. Casamitjana. Servicio de Hormonología. Hospital Clínic. Villarroel, 170. 08036 Barcelona. España.
Servicio de Hormonología. Hospital Clínic. IDIBAPS. Barcelona. España
This item has received
Article information

Las pruebas dinámicas han sido, durante muchos años, fundamentales en el diagnóstico de muchas enfermedades endocrinas. En la actualidad, su aplicación, aunque imprescindible en algunas exploraciones endocrinológicas, ha disminuido, y ello por varios factores: a) la aplicación de nuevos métodos de laboratorio más sensibles, precisos y rápidos; b) la posibilidad de valoración de nuevos parámetros hormonales con la suficiente fiabilidad; c) la introducción de nuevos métodos diagnósticos, y d) el desarrollo de exploraciones complementarias, especialmente en el campo de la imagen.

Por otro lado, el mejor conocimiento del funcionamiento de los distintos ejes endocrinos y la tendencia a disminuir los costes de las exploraciones han contribuido a utilizar las pruebas dinámicas sólo en aquellos casos en los que su uso resulta realmente imprescindible.

For many years, dynamic tests have been essential to the diagnosis of many endocrine disorders. Currently, although they remain essential in certain endocrinological investigations, their use has diminished due to many factors: a) the application of new laboratory methods that are more sensitive, accurate, and rapid; b) the possibility of measuring new hormones in plasma with sufficient reliability; c) the introduction of new diagnostic methods, and d) the increase of other complementary investigations, especially imaging techniques.

In addition, because of improved knowledge of the behavior of the endocrine axis and the tendency to reduce the costs of diagnosis, dynamic tests of endocrine function are now used only when essential.

Palabras clave:
Deficiencia de GH
Función tiroidea
Insuficiencia suprarrenal
Tests funcionales
Key words:
GH deficiency
Thyroid function
Adrenal insufficiency
Functional tests
Full text is only aviable in PDF
Bibliografía
[1.]
P. Vidal-Ríos, A. Caixàs, R. Cabezas, P. Cajas, A. García-Patterson, et al.
Análisis crítico de la utilidad y coste del megatest en el manejo de los tumores hipofisarios.
Endocrinología, 41 (1994), pp. 75-80
[2.]
J. Butler.
Biochemical tests of growth hormone status in short children.
Ann Clin Biochem, 38 (2001), pp. 1-23
[3.]
E. Torres, A. Leal-Cerro, F.F. Casanueva.
Diagnóstico del déficit de hormona de crecimiento en pacientes adultos.
Endocrinol Nutr, 49 (2002), pp. 313-315
[4.]
Growth Hormone Research Society.
Consensus guidelines for the diagnosis and treatment of adults with GH deficiency: summary statement of Growth Hormone Research Society Workshop on adult growth hormone deficiency.
J Clin Endocrinol Metab, 83 (1998), pp. 379-381
[5.]
D.O. Hoffman, A. O'Sullivan, R.C. Baxter, K.Y. Ho.
Diagnosis of growth hormone deficiency in adults.
Lancet, 343 (1994), pp. 1064-1068
[6.]
C. Diéguez, F.F. Casanueva.
Influence of metabolic substrates and obesity in growth hormone secretion.
Trends Endocrinol Metab, 6 (1995), pp. 55-59
[7.]
G. Aimaretti, G. Cornelli, P. Razzore, S. Bellone, C. Baffoni, E. Arvat, et al.
Comparison between insulin-induced hipoglycemia ang growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.
J Clin Endocrinol Metab, 83 (1998), pp. 1615-1618
[8.]
V. Popovic, A. Leal, D. Micic, H.P.F. Kopeschaar, E. Torres, C. Páramo, et al.
GH-releasing hormone plus GH-releasing peptide-6 in adults with GH deficiency.
Lancet, 356 (2000), pp. 1137-1142
[9.]
J.M. Gómez, R.M. Espadero, F. Escobar-Jiménez, F. Hawkins, A. Picó, J.L. Herrera-Pombo, et al.
Growth hormone release after glucagon as a reliable test of growth hormone assessment in adults.
Clin Endocrinol (Oxf), 56 (2002), pp. 329-334
[10.]
R. Peino, R. Baldelli, J. Rodríguez-García, S. Rodríguez-Segade, M. Kojima, et al.
Ghrelin-induced growth hormone secretion in humans.
Eur J Endocrinol, 143 (2000), pp. R11-R14
[11.]
M.L. Hartman, B.J. Crowe, B.M.K. Biller, K.K.Y. Ho, D.R. Clemons, J.J. Chipman.
on behalf of The HypCCS advisory board and the US. HypoCCS Study group Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?.
J Clin Endocrinol Metab, 87 (2002), pp. 477-485
[12.]
P.U. Freda, K.D. Post, J.S. Powell, S.L. Wardlaw.
Evaluation of disease status with sensitive measurements of growth hormones secretion in 60 postoperative patients with acromegaly.
J Clin Endocrinol Metab, 83 (1998), pp. 3808-3816
[13.]
P. Beck-Peccoz, F. Brucker-Davis, L. Persani, R.C. Smallridge, B.D. Weintraub.
Thyrotropin-secreting pituitary tumors.
Endocr Rev, 17 (1996), pp. 610-638
[14.]
F. Brucker-Davis, E.H. Oldfield, M.C. Skarulis, J.L. Doppman, B.D. Weintraub.
Thyrotropin-secreting pituitary tumors: diagnostic criteria, thyroid hormone sensitivity and treatment outcome in 25 patients followed at the National Institutes of Health.
J Clin Endocrinol Metab, 84 (1999), pp. 476-486
[15.]
P. Chanson, J. Pantel, J. Young, B. Couzinet, J-M Bidart, G. Schaison.
Free luteinizing-hormone beta-subunit in normal subjects and in patients with pituitary adenomas.
J Clin Endocrinol Metab, 82 (1997), pp. 1397-1402
[16.]
D. Somjen, K. Tordjman, F. Kohen, M. Baz, N. Razon, et al.
Combined bFSH and bLH response to TRH in patients with clinically non-functioning pituitary adenomas.
Clin Endocrinol, 46 (1997), pp. 555-562
[17.]
P.W. Ladenson, L.E. Braverman, E.L. Mazzaferri, F. Brucker-Davis, D.S. Cooper, et al.
Comparison of administration of recombinant human tyrotropin with withdrawal of thyroid administration for radioactive iodine scanning in patients with tyroid carcinoma.
N Engl J Med, 337 (1997), pp. 888-896
[18.]
E.L. Mazzaferri, R.T. Kloos.
Is diagnostic iodine-131scanning with recombinant human TSH useful in the follow-up of differenciated thyroid cancer after thyroid ablation?.
J Clin Endocrinol Metab, 87 (2002), pp. 1490-1498
[19.]
L.F. Baudin, E. Chieferi, F. Arturi, S. Bardet, B. Caillou, et al.
Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804.
J Clin Endocrinol Metab, 87 (2002), pp. 1674-1680
[20.]
E. Erturk, A. Craig, A. Jaffe, A.L. Barkan.
Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test.
J Clin Endocrinol Metab, 83 (1998), pp. 2350-2354
[21.]
R. Alfayate, M. Mauri, M. de Torre, C. Pardo, A. Picó.
Prueba de la hipoglucemia insulínica en la exploración del eje hipotálamo-hipófisis-suprarrenal.
Med Clin (Barc), 18 (2002), pp. 441-445
[22.]
I. Halperin, M.J. Martínez de Osaba.
Valoración de la función hipotálamo-hipófiso-suprarrenal en la insuficiencia suprarrenal.
Endocrinol Nutr, 46 (1999), pp. 261-264
[23.]
J. Oriola.
Diagnóstico molecular de los déficit de 21-hidroxilasa y su correlación con el fenotipo.
Endocrinología, 46 (1999), pp. 168-172
Copyright © 2003. Sociedad Española de Endocrinología y Nutrición
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos